Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of medical diagnostic tests. The company offers two versions of a real-time Neuraminidase Inhibitor assay, which is designed for influenza diagnosis and drug resistance detection.
You’re viewing a free company profile from the PitchBook Platform. To explore Cellex’s full profile, request a free trial.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.